Publication Name	World Journal of Hepatology
Manuscript ID	11371
Country	Greece

Received	2014-05-18 16:10
Peer-Review Started	2014-05-18 22:44
To Make the First Decision	2014-06-06 11:02
Return for Revision	2014-06-16 11:10
Revised	2014-06-22 22:48
Second Decision	2014-09-10 13:39
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-09-10 14:01
Articles in Press	2014-09-10 14:01
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-10-27 15:03
Publish the Manuscript Online	2014-11-05 09:07

ISSN	1948-5182 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Lipid-lowering agents in the management of nonalcoholic fatty liver disease
Manuscript Source	Invited Manuscript
All Author List	Konstantinos Tziomalos
Funding Agency and Grant Number
Corresponding Author	Konstantinos Tziomalos, MD, PhD, First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Kiriakidi 1, 54636 Thessaloniki, Greece. ktziomalos@yahoo.com
Key Words	Nonalcoholic fatty liver disease; Statins; Fibrates; Ezetimibe; Colesevelam; Omega-3 fatty acids; Nicotinic acid; Cardiovascular disease; Transaminases; Nonalcoholic steatohepatitis
Core Tip	Accumulating data suggest that statins are safe in patients with nonalcoholic fatty liver disease (NAFLD) and that they reduce the increased cardiovascular morbidity of this population. However, it is still unclear whether statins are also useful as a treatment for NAFLD per se, since there are very limited and conflicting data on their effects on liver histology. There is also very scarce evidence regarding the safety and efficacy of other lipid-lowering agents in patients with NAFLD.
Publish Date	2014-11-05 09:07
Citation	Tziomalos K. Lipid-lowering agents in the management of nonalcoholic fatty liver disease. World J Hepatol 2014; 6(10): 738-744
URL	http://www.wjgnet.com/1948-5182/full/v6/i10/738.htm
DOI	http://dx.doi.org/10.4254/wjh.v6.i10.738

Full Article (PDF)	WJH-6-738.pdf
Full Article (Word)	WJH-6-738.doc
Manuscript File	11371-Review.docx
Answering Reviewers	11371-Answering reviewers.pdf
Copyright License Agreement	11371-Copyright assignment.pdf
Peer-review Report	11371-Peer review(s).pdf
Scientific Misconduct Check	11371-CrossCheck.jpg
Scientific Editor Work List	11371-Scientific editor work list.pdf